Omada Health, Inc. (NASDAQ:OMDA) Receives Consensus Rating of “Moderate Buy” from Analysts

Omada Health, Inc. (NASDAQ:OMDA) has received a consensus rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $26.50.

Several equities research analysts have commented on OMDA shares. BTIG Research upped their price objective on Omada Health from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Barclays raised their price target on shares of Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research report on Friday, May 8th.

Insiders Place Their Bets

In related news, President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $25.02, for a total value of $221,827.32. Following the completion of the transaction, the president owned 307,372 shares in the company, valued at $7,690,447.44. The trade was a 2.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Steven L. Cook sold 1,607 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $25.01, for a total value of $40,191.07. Following the completion of the transaction, the chief financial officer directly owned 187,209 shares of the company’s stock, valued at $4,682,097.09. The trade was a 0.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 254,726 shares of company stock valued at $5,370,496 over the last quarter. Insiders own 6.38% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in OMDA. Corient Private Wealth LP grew its stake in Omada Health by 252.5% in the 2nd quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock valued at $3,185,000 after acquiring an additional 103,955 shares during the period. California State Teachers Retirement System increased its holdings in Omada Health by 465.1% in the 2nd quarter. California State Teachers Retirement System now owns 10,229 shares of the company’s stock worth $225,000 after acquiring an additional 8,419 shares in the last quarter. Round Rock Advisors LLC acquired a new position in Omada Health during the second quarter worth $745,000. Susquehanna Fundamental Investments LLC acquired a new position in Omada Health during the second quarter worth $503,000. Finally, Hsbc Holdings PLC purchased a new position in Omada Health during the second quarter valued at $435,000.

Omada Health Price Performance

Shares of OMDA opened at $23.69 on Monday. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 473.80 and a beta of 1.73. Omada Health has a 52 week low of $10.28 and a 52 week high of $26.92. The stock’s 50-day moving average price is $22.27 and its 200-day moving average price is $17.20.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The company had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. As a group, equities analysts anticipate that Omada Health will post 0.09 EPS for the current fiscal year.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.